Armistice Capital’s Core Scientific CORZ Stock Holding History

Armistice Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,589	Closed	-$285K	–	310
2025 Q4	$285K	Buy	+19,589	New	+$342K	﹤0.01%	301

Other funds holding CORZ

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Armistice Capital's CORZ Position: Q1 2026 in Review

Armistice Capital sold out of Core Scientific (CORZ) in Q1 2026, closing a stake of 19,589 shares — an estimated $285K sold.

Armistice Capital first reported a position in CORZ in Q4 2025 and held it in 1 quarter. The position peaked at $285K in Q4 2025. 387 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

Armistice Capital reported no remaining Core Scientific position as of Q1 2026 after selling out during the quarter.
Armistice Capital sold 19,589 Core Scientific shares in Q1 2026, an estimated $285K.
Armistice Capital first reported a position in Core Scientific in Q4 2025 and held it in 1 quarter.
Armistice Capital's Core Scientific position peaked at $285K in Q4 2025.
387 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.